Product Code: ETC11390478 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antiemetics Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antiemetics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antiemetics Drugs Market - Industry Life Cycle |
3.4 India Antiemetics Drugs Market - Porter's Five Forces |
3.5 India Antiemetics Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Antiemetics Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Antiemetics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Antiemetics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting in cancer patients |
4.2.2 Growing awareness about the availability and benefits of antiemetic drugs |
4.2.3 Rising geriatric population in India prone to nausea and vomiting |
4.2.4 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antiemetic drugs |
4.3.2 Side effects associated with certain antiemetics leading to patient reluctance |
4.3.3 Competition from alternative therapies such as acupuncture and herbal remedies |
5 India Antiemetics Drugs Market Trends |
6 India Antiemetics Drugs Market, By Types |
6.1 India Antiemetics Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Antiemetics Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Antiemetics Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists, 2021 - 2031F |
6.1.4 India Antiemetics Drugs Market Revenues & Volume, By Dopamine Antagonists, 2021 - 2031F |
6.1.5 India Antiemetics Drugs Market Revenues & Volume, By NK1 Receptor Antagonists, 2021 - 2031F |
6.2 India Antiemetics Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Antiemetics Drugs Market Revenues & Volume, By Chemotherapy-Induced Nausea, 2021 - 2031F |
6.2.3 India Antiemetics Drugs Market Revenues & Volume, By Motion Sickness, 2021 - 2031F |
6.2.4 India Antiemetics Drugs Market Revenues & Volume, By Post-Surgical Nausea, 2021 - 2031F |
6.3 India Antiemetics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Antiemetics Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 India Antiemetics Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 India Antiemetics Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 India Antiemetics Drugs Market Import-Export Trade Statistics |
7.1 India Antiemetics Drugs Market Export to Major Countries |
7.2 India Antiemetics Drugs Market Imports from Major Countries |
8 India Antiemetics Drugs Market Key Performance Indicators |
8.1 Number of new antiemetic drug approvals by regulatory authorities in India |
8.2 Patient adherence rates to prescribed antiemetic medication regimens |
8.3 Number of healthcare facilities offering antiemetic drugs and services |
8.4 Percentage of oncologists recommending antiemetics as part of cancer treatment |
8.5 Patient satisfaction surveys regarding the effectiveness and tolerability of antiemetic drugs |
9 India Antiemetics Drugs Market - Opportunity Assessment |
9.1 India Antiemetics Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Antiemetics Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Antiemetics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Antiemetics Drugs Market - Competitive Landscape |
10.1 India Antiemetics Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antiemetics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |